A Study in Patients With Mixed Dyslipidemia

PHASE2RecruitingINTERVENTIONAL
Enrollment

132

Participants

Timeline

Start Date

February 28, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

March 30, 2028

Conditions
Mixed Dyslipidemia
Interventions
DRUG

BW-00112

BW-00112 or volume-matched placebo on Day 1 and Day 90

Trial Locations (14)

30114

RECRUITING

East Coast Institute for Research LLC, Canton

32204

COMPLETED

East Coast Institute for Research, LLC, Jacksonville

33135

RECRUITING

Suncoast Research Group, LLC DBA Flourish Research, Miami

33186

RECRUITING

Clinical Site Partners, LLC DBA Flourish Research, Miami

33434

RECRUITING

Excel Medical Clinical Trials, LLC, dba Flourish Research, Boca Raton

34748

RECRUITING

Clinical Site Partners Leesburg, LLC dba Flourish Research, Leesburg

36526

RECRUITING

Alliance for Multispecialty Research, LLC, Daphne

36608

RECRUITING

Alliance for Multispecialty Research, LLC, Mobile

60068

RECRUITING

Alliance for Multispecialty Research, LLC, Park Ridge

60523

RECRUITING

Alliance for Multispecialty Research, LLC, Oak Brook

67114

RECRUITING

Alliance for Multispecialty Research, LLC, Newton

73069

RECRUITING

Alliance for Multispecialty Research, LLC, Norman

78229

RECRUITING

Clinical Trials of Texas, LLC, San Antonio

10029-6574

RECRUITING

Icahn School of Medicine at Mount Sinai, New York

All Listed Sponsors
lead

Shanghai Argo Biopharmaceutical Co., Ltd.

INDUSTRY